The RNAi race: Tekmira signs $50 million deal with Roche while Calando watches

May 19, 2009 | Analyst Insight

With the recent flurry of funding and failing of emerging technology companies in the pharmaceutical arena, start-ups everywhere are fearing upcoming judgment days, requiring them to either establish partnerships or close...